美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NorthView Acquisition Corp

10.05

0.0000

成交量：- -

成交額：- -

市值：1.91億

市盈率：- -

高：10.05

開：10.05

低：10.05

收：10.05

52周最高：10.05

52周最低：10.05

股本：1,897.50萬

流通股本：1,699.64萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：-510.09

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

NorthView Acquisition Corp

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.profusa.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Profusa, Inc.於2021年4月19日作為特拉華州公司註冊成立。該公司是一家数字健康技術公司，開發了一種皮下生物傳感器平台Lumee，旨在提供實時的個體生物化學數據。其首款產品Lumee Oxygen已獲得歐盟CE認證，同時公司正在開發用於糖尿病管理的Lumee Glucose。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/NVACU/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVACU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVACU\",,,,,undefined,":{"symbol":"NVACU","market":"US","secType":"STK","nameCN":"NorthView Acquisition Corp","latestPrice":10.05,"timestamp":1787667779026,"preClose":10.05,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":16996417,"shares":18975000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"08-25 10:22:59 EDT","open":10.05,"high":10.05,"low":10.05,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1639976400000,"exchange":"NASDAQ","adjPreClose":10.05,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVACU\",,,,,undefined,":{"symbol":"NVACU","floatShares":16996417,"roa":"--","roe":"--","lyrEps":0,"shares":18975000,"dividePrice":0,"high":10.05,"amplitude":0,"preClose":10.05,"low":10.05,"week52Low":10.05,"pbRate":"-510.09","week52High":10.05,"institutionHeld":0,"latestPrice":10.05,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":10.05,"prevYearClose":10.05,"prevWeekClose":10.05,"prevMonthClose":10.05,"prevQuarterClose":10.05,"fiveDayClose":10.05,"twentyDayClose":10.05,"sixtyDayClose":10.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVACU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-01-24","symbol":"NVACU","reason":null,"defaultRemindTime":1643034600000,"announcedDate":"2022-01-21","type":"delisting","dateTimestamp":1643000400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVACU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVACU\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.profusa.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Profusa, Inc.於2021年4月19日作為特拉華州公司註冊成立。該公司是一家数字健康技術公司，開發了一種皮下生物傳感器平台Lumee，旨在提供實時的個體生物化學數據。其首款產品Lumee Oxygen已獲得歐盟CE認證，同時公司正在開發用於糖尿病管理的Lumee Glucose。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.000012},{"month":2,"riseRate":0,"avgChangeRate":0},{"month":3,"riseRate":0,"avgChangeRate":0},{"month":4,"riseRate":0,"avgChangeRate":0},{"month":5,"riseRate":0,"avgChangeRate":0},{"month":6,"riseRate":0,"avgChangeRate":0},{"month":7,"riseRate":0,"avgChangeRate":0},{"month":8,"riseRate":0,"avgChangeRate":0},{"month":9,"riseRate":0,"avgChangeRate":0},{"month":10,"riseRate":0,"avgChangeRate":0},{"month":11,"riseRate":0,"avgChangeRate":0},{"month":12,"riseRate":0,"avgChangeRate":0}],"exchange":"NASDAQ","name":"NorthView Acquisition Corp","nameEN":"NorthView Acquisition Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NVACU\",market:\"US\",,,undefined,":null}}